Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 585, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ijpharm.2020.119476
Keywords
Neurodegeneration; Curcumin; Blood-brain barrier; Nanotechnology; Drug delivery
Categories
Funding
- cancer research center of cancer institute of Iran (Shams cancer charity) [37312-202-01-97, 960206]
- Biotechnology Development Council of the Islamic Republic of Iran
Ask authors/readers for more resources
Neurodegenerative diseases are a major global public health concern in the elderly population but therapeutic options are limited. Curcumin is a hydrophobic polyphenol extracted from the dried rhizomes of Curcuma longa L. and shows good potential for the treatment of neurodegenerative diseases and brain tumors. The blood-brain barrier (BBB) is the major obstacle for the delivery of curcumin into the brain, limiting its therapeutic potential. The development of promising approaches to facilitate curcumin transportation across the BBB may resolve some of the problems associated with drug delivery. Studies have shown nano delivery of curcumin can improve a number of outcome measures in neurodegenerative diseases. The present review highlights current and emerging strategies to facilitate curcumin permeation across the BBB for the treatment of various neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available